• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平均随访 13 年后非骨水泥型髋关节柄存留的长期生存率:单纯髋臼翻修的结果

Long-Term Survival of Retained Cementless Hip Stems at an Average of 13 Years After Isolated Cup Revision.

机构信息

Clinic for Orthopedics and Trauma Surgery, Center for Orthopedics, Trauma Surgery and Spinal Cord Injury, Heidelberg University Hospital (M.M.I., D.S.P., C.M., B.M., and M.R.S.) and Institute of Medical Biometry and Informatics (T.B.), University of Heidelberg, Heidelberg, Germany.

Department of Orthopedics, Kepler University Hospital, Linz, Austria.

出版信息

J Bone Joint Surg Am. 2019 Feb 6;101(3):265-269. doi: 10.2106/JBJS.18.00159.

DOI:10.2106/JBJS.18.00159
PMID:30730486
Abstract

BACKGROUND

Cementless stems demonstrate excellent long-term survival, but little is known about the long-term survival rate of the stem after isolated cup revision. The aim of the present retrospective cohort study was to determine the long-term survival rate of cementless stems retained after prior cup revision.

METHODS

We reviewed the clinical and radiographic results of 119 total hip arthroplasties (THAs) utilizing a cementless, grit-blasted, tapered titanium femoral stem that were performed in 113 patients between January 1985 and December 1989. The mean age at the time of the primary THA was 52 years (range, 16 to 74 years) and the mean time between primary THA and cup revision was 13 years (standard deviation [SD], 6 years; range, 0 to 30 years). At the time of the latest follow-up, no patient was lost to follow-up, 36 patients representing 37 hips had died, and 11 hips in 11 patients had required stem revision. The mean follow-up was 13 years following cup revision (SD, 6 years; range, 0 to 28 years). A competing risk analysis was performed to estimate the survival of the stem after isolated cup revision, with death being the competing risk factor.

RESULTS

At 20 years after cup revision, the survival rate of retained stems was 89% (95% confidence interval [CI], 79% to 94%) for the end point of stem revision for any reason and 97% (95% CI, 91% to 99%) for the end point of stem revision for aseptic loosening.

CONCLUSIONS

The long-term survival of cementless stems retained after cup revision was excellent. Well-fixed cementless stems should be retained during cup revision for aseptic loosening.

LEVEL OF EVIDENCE

Level IV. See Instructions for Authors for a complete description of levels of evidence.

摘要

背景

非骨水泥固定的股骨柄具有出色的长期生存率,但对于在初次髋关节置换术(THA)后进行单纯髋臼翻修时股骨柄的长期生存率知之甚少。本回顾性队列研究的目的是确定在初次 THA 后进行单纯髋臼翻修时保留的非骨水泥固定、喷砂酸蚀、锥形钛制股骨柄的长期生存率。

方法

我们回顾了 1985 年 1 月至 1989 年 12 月期间 113 名患者的 119 例初次 THA 应用非骨水泥固定、喷砂酸蚀、锥形钛制股骨柄的临床和影像学结果。初次 THA 时的平均年龄为 52 岁(范围:16 岁至 74 岁),初次 THA 与髋臼翻修之间的平均时间为 13 年(标准差[SD],6 年;范围:0 年至 30 年)。在末次随访时,无患者失访,36 名患者(37 髋)死亡,11 名患者(11 髋)需要进行股骨柄翻修。髋臼翻修后的平均随访时间为 13 年(SD,6 年;范围:0 年至 28 年)。采用竞争风险分析来估计单纯髋臼翻修后股骨柄的生存率,死亡是竞争风险因素。

结果

髋臼翻修后 20 年,对于任何原因导致的股骨柄翻修的终点,保留的股骨柄的生存率为 89%(95%置信区间[CI],79%至 94%),对于无菌性松动导致的股骨柄翻修的终点,生存率为 97%(95%CI,91%至 99%)。

结论

髋臼翻修后保留的非骨水泥固定股骨柄具有优异的长期生存率。对于无菌性松动,在髋臼翻修时应保留固定良好的非骨水泥固定股骨柄。

证据等级

IV 级。详见《作者须知》,以获取完整的证据等级描述。

相似文献

1
Long-Term Survival of Retained Cementless Hip Stems at an Average of 13 Years After Isolated Cup Revision.平均随访 13 年后非骨水泥型髋关节柄存留的长期生存率:单纯髋臼翻修的结果
J Bone Joint Surg Am. 2019 Feb 6;101(3):265-269. doi: 10.2106/JBJS.18.00159.
2
What Is the Long-term (27- to 32-year) Survivorship of an Uncemented Tapered Titanium Femoral Component and Survival in Patients Younger Than 50 Years?非骨水泥锥形钛合金股骨部件的 27-32 年长期生存率是多少?50 岁以下患者的生存率如何?
Clin Orthop Relat Res. 2020 Jun;478(6):1283-1291. doi: 10.1097/CORR.0000000000001203.
3
Long-term (20- to 25-year) results of an uncemented tapered titanium femoral component and factors affecting survivorship.非骨水泥锥形钛合金股骨部件的长期(20-25 年)结果和影响生存率的因素。
Clin Orthop Relat Res. 2013 Oct;471(10):3262-9. doi: 10.1007/s11999-013-3033-4. Epub 2013 May 14.
4
Fate of the unrevised cemented stem following cup only revision: 227 hips at an average of 6 years follow-up.仅进行髋臼翻修后未翻修骨水泥型股骨柄的转归:227例髋关节,平均随访6年。
Orthop Traumatol Surg Res. 2015 Nov;101(7):781-4. doi: 10.1016/j.otsr.2015.08.005. Epub 2015 Oct 20.
5
Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry.55岁及以上原发性骨关节炎患者的全髋关节置换术。芬兰关节置换登记处的分析。
J Bone Joint Surg Am. 2008 Oct;90(10):2160-70. doi: 10.2106/JBJS.G.00870.
6
Minimum 10-Year Follow-Up of Cementless Total Hip Arthroplasty Using a Contemporary Triple-Tapered Titanium Stem.使用当代三锥度钛柄非骨水泥型全髋关节置换术的至少10年随访
J Arthroplasty. 2016 Oct;31(10):2231-6. doi: 10.1016/j.arth.2016.04.037. Epub 2016 May 11.
7
The 21- to 27-year results of the Harris-Galante cementless total hip arthroplasty.哈里斯-加兰特非骨水泥型全髋关节置换术21至27年的随访结果。
J Orthop Sci. 2016 May;21(3):342-7. doi: 10.1016/j.jos.2016.02.004. Epub 2016 Mar 9.
8
Increased risk of periprosthetic femur fractures associated with a unique cementless stem design.与一种独特的非骨水泥型股骨柄设计相关的假体周围股骨骨折风险增加。
Clin Orthop Relat Res. 2015 Jun;473(6):2045-53. doi: 10.1007/s11999-014-4077-9. Epub 2014 Dec 12.
9
Long-term survivorship of the Corail™ standard stem.Corail™标准柄的长期生存率
Orthop Traumatol Surg Res. 2017 Nov;103(7):987-992. doi: 10.1016/j.otsr.2017.06.010. Epub 2017 Aug 1.
10
How Does Implant Survivorship Vary with Different Corail Femoral Stem Variants? Results of 51,212 Cases with Up to 30 Years Of Follow-up from the Norwegian Arthroplasty Register.不同 Corail 股骨柄型号的假体生存率如何变化?来自挪威关节置换登记处的最长 30 年随访的 51212 例结果。
Clin Orthop Relat Res. 2021 Oct 1;479(10):2169-2180. doi: 10.1097/CORR.0000000000001940.

引用本文的文献

1
Survivorship of the retained femoral component after revision total hip arthroplasty: A systematic review and meta-analysis.翻修全髋关节置换术后保留股骨假体的生存率:一项系统评价和荟萃分析。
Front Surg. 2022 Oct 13;9:988915. doi: 10.3389/fsurg.2022.988915. eCollection 2022.